Olivia Brayer
Stock Analyst at Cantor Fitzgerald
(0.51)
# 1521
Out of 5,298 analysts
102
Total ratings
54.39%
Success rate
6.96%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BMRN Biomarin Pharmaceuti... | Reiterates: Overweight | 90 90 | 67.44 | 33.45% | 15 | Feb 20, 2025 | |
VRTX Vertex Pharmaceutica... | Reiterates: Overweight | 480 480 | 484 | -0.83% | 22 | Feb 11, 2025 | |
BMY Bristol-Myers Squibb | Maintains: Neutral | 50 55 | 57.69 | -4.66% | 9 | Feb 4, 2025 | |
GILD Gilead Sciences | Reiterates: Neutral | 80 80 | 112.39 | -28.82% | 10 | Dec 11, 2024 | |
OMER Omeros | Reiterates: Neutral | n/a | n/a | n/a | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 1015 1015 | 610.24 | 66.33% | 8 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 405 405 | 310.12 | 30.59% | 2 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 220 220 | 262.05 | -16.05% | 23 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 8.04 | 24.38% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 7 7 | 4.87 | 33.47% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 72 | 32.67 | 120.39% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 56 21 | n/a | n/a | 2 | Feb 23, 2023 |